Comparison

Therapeutic ketamine vs psychedelic microdosing

Microdosing psilocybin or LSD has grown popular but lacks robust controlled evidence. Therapeutic ketamine operates at meaningfully different doses, in clinical settings, with stronger short-term data.

Written by: Ira ZootMedical review status: Not yet clinically reviewed.Last updated: June 4, 2026Evidence: Educational synthesis - not medical advice

This page has been written and edited by the publisher. It has not been reviewed by a licensed clinician.

Quick answer

Bottom line

These are not in the same category. Therapeutic ketamine is a regulated medical treatment with clinical evidence; microdosing remains an unregulated practice with limited controlled support.

This page compares Therapeutic ketamine and Psychedelic microdosing across the same fixed dimensions - mechanism, evidence, onset, duration, side effects, access, suitability, and limits. It does not name a winner and does not recommend either option for you.

Related on Ketalux

Therapeutic ketamine

Psychedelic microdosing

Mechanism

Sub-anesthetic ketamine producing measurable glutamate surge and plasticity.

Sub-perceptual doses of classical psychedelics; mechanism in mood regulation unclear.

Evidence

Multiple positive RCTs in TRD, anxiety, PTSD.

Self-report studies dominate; controlled trials mostly fail to separate microdosing from placebo.

Onset

Hours.

Subjective; effects often not clinically replicable.

Duration

Days to weeks per dose.

Variable, often tied to expectation effects.

Side effects

Transient dissociation, BP rise, nausea, monitored setting.

Anxiety, sleep disruption, cardiac concerns with chronic use, legality issues in most jurisdictions.

Access

Licensed clinics.

Illegal in most jurisdictions; unregulated supply.

Best for

Patients seeking evidence-based, supervised treatment.

Currently lacks evidence base to recommend clinically.

Limits

Cost, access.

Weak evidence, legal risk, unknown long-term safety.

Disclaimer

This comparison is educational and general. It is not a recommendation. Treatment choice depends on your individual history, diagnosis, prior response, preferences, and access - discuss with a qualified clinician.

About the author

Ira Zoot

Publisher and editor of Ketalux, based in Chicago, Illinois. Ira is a ketamine therapy patient, not a clinician. This is editorial review, not medical review: Ira is not a licensed clinician and does not provide diagnosis or medical care. Ketalux does not accept compensation from providers in exchange for favorable editorial coverage, evidence ratings, recommendations, patient referrals, or organic provider ranking. Read the full publisher disclosure →

Educational use only. The content on this page is provided for general educational purposes and does not constitute medical advice, diagnosis, or treatment. Ketamine and related therapies carry risks and are appropriate only under qualified medical supervision. Always consult a licensed healthcare professional about your individual situation. Information may change as research evolves.